New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 10, 2013
04:55 EDTGHDX, GHDX, GHDX, GHDX, GHDX, VSTM, VSTM, VSTM, VSTM, VSTM, CLSN, CLSN, CLSN, CLSN, CLSN, ATOS, ATOS, ATOS, ATOS, ATOS, MACK, MACK, MACK, MACK, MACKCancer Therapy & Research Center to hold a conference
2013 San Antonio Breast Cancer Conference is being held in San Antonio, Texas on December 10-14.
News For GHDX;VSTM;CLSN;ATOS;MACK From The Last 14 Days
Check below for free stories on GHDX;VSTM;CLSN;ATOS;MACK the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 22, 2014
08:15 EDTGHDXGenomic Health announces two important international milestones
Genomic Health announced two important international milestones including additional reimbursement in Canada and the inclusion of the Oncotype DX breast cancer test in major German clinical guidelines. In Canada, the BC Cancer Agency in British Columbia agreed to fund the Oncotype DX breast cancer test for eligible patients, expanding reimbursement to more than 80% of the country's population. In Germany, updated guidelines from the AGO, or Gynecologic Oncology Working Group, now recommend the Oncotype DX breast cancer test as the only gene expression test to predict chemotherapy benefit in early-stage hormone receptor-positive invasive breast cancer.
April 10, 2014
12:12 EDTVSTMVerastem management to meet with Roth Capital
Subscribe for More Information
April 9, 2014
08:03 EDTCLSNCelsion announces data supporting development of ThermoDox
Celsion announced that data supporting the development of ThermoDox, its proprietary heat-activated liposomal encapsulation of doxorubicin, plus high intensity focused ultrasound were presented at the International Symposium on Therapeutic Ultrasound. Mark Dewhirst, D.V.M., Ph.D. presented data demonstrating the potential of ThermoDox plus HIFU to maximize drug delivery to the targeted tumor site. Celsion is exploring the potential of ThermoDox in combination with HIFU as a non-invasive treatment for a variety of cancers, including pancreatic cancer, Glioblastoma Multiforme, metastatic liver cancer, and breast cancer.
07:01 EDTVSTMVerastem presents data on cancer stem cell-targeting agents at AACR
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use